Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis
Clinical trial NCT01435993 · TERMINATED
Trial details
- NCT number
- NCT01435993
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-08
- Primary completion
- 2012-01-23
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.